$98.00
+1.85 (+1.92%)
Performance
1D
—
1W
—
1M
—
3M
-5.86%
6M
+15.51%
1Y
+32.56%
YTD
-2.82%
Open$97.47
Previous Close$96.15
Day High$100.67
Day Low$97.08
52W High$113.02
52W Low$55.54
Volume—
Avg Volume504.0K
Market Cap7.63B
P/E Ratio—
EPS$-5.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$103.76
Below
SMA 200
$88.57
Above
RSI (14)
53.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-66.0% upside
Current
$98.00
$98.00
Target
$33.28
$33.28
$20.12
$33.28 avg
$44.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.56B | 1.45B | 1.21B |
| Net Income | -302,764,100 | -377,638,036 | -264,320,064 |
| Profit Margin | -19.4% | -26.0% | -21.8% |
| EBITDA | -533,448,597 | -500,050,490 | -459,692,337 |
| Free Cash Flow | -391,442,676 | -279,670,611 | -274,115,194 |
| Rev Growth | +10.6% | +5.5% | +20.0% |
| Debt/Equity | 0.68 | 0.65 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |